Explore Thermo Fisher Scientific Inc.'s valuation, modest growth challenges, and recent M&A moves. Click for my updated look ...

PPD. Weaker demand for drug manufacturing in recent years led to Thermo Fisher taking several cost-cutting initiatives, including cutting jobs at its plasmid manufacturing site in California ...

Thermo Fisher Scientific said Tuesday it is buying Solventum’s purification and filtration business, confirming an earlier ...

The global Clinical Trial Services Market, valued at US$60.76 billion in 2024, is forecasted to grow at a robust CAGR of 8.9% ...

part of the PPD™ clinical research business of Thermo Fisher Scientific. “High-quality, real-world data can drive much-needed insights on novel treatments and provide hope for patients ...

Thermo Fisher Scientific CIO Ryan Snyder believes business strategy and tech strategy should be woven together and that data ...

The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of ...

This is the 12 th independent registry from CorEvitas, part of the PPD™ clinical research business of Thermo Fisher Scientific. It complements an existing CorEvitas registry focused on AA in ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced Karen S. Lynch has been elected to its board of directors, effective ...

Waltham-based Thermo is buying the business from Solventum, a Minnesota-based company that spun off from manufacturing conglomerate 3M roughly one year ago.